Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Head

Showing results (301-310 of 364) with videos related to

Pageof 37
Sort By:
Medrxiv : the Preprint Server for Health Sciences|December 16, 2024
The striatum is an early, accurate indicator of amyloid burden using [<sup>11</sup>C]PiB in Down syndrome: comparison of two radiotracersMax McLachlan, Brecca Bettcher, Andrew McVea, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 25, 2025
PET-measured amyloid beta accumulates at an accelerated rate in Down syndrome compared to neurotypical populationsAndrew McVea, Alexandra DiFilippo, Max McLachlan, et al.
Ebiomedicine|November 5, 2024
The effects of mosaicism on biological and clinical markers of Alzheimer's disease in adults with Down syndromeLaura Xicota, Lam-Ha T Dang, Alice Lee, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 21, 2026
The impact of congenital heart disease on the timing of Alzheimer's disease in Down syndromeJulianne G Clina, Brian C Helsel, Sigan L Hartley, et al.
Scientific Data|July 29, 2023
Multimodal neuroimaging data from a 5-week heart rate variability biofeedback randomized clinical trialHyun Joo Yoo, Kaoru Nashiro, Jungwon Min, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 7, 2020
Proteomic profiles for Alzheimer's disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimer's Biomarker Consortium-Down Syndrome (ABC-DS) studyMelissa E Petersen, Fan Zhang, Nicole Schupf, et al.
Medrxiv : the Preprint Server for Health Sciences|June 17, 2024
A Neuropathology Case Report of a Woman with Down Syndrome who Remained Cognitively StableJr-Jiun Liou, Jerry Lou, Jamie Nakagiri, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 16, 2025
Genome-wide association analyses identify candidate loci for amyloid imaging and plasma biomarkers in adults with Down syndromeM Muaaz Aslam, Lam-Ha T Dang, Ruyu Shi, et al.
Cell|June 24, 2022
Cholesterol and matrisome pathways dysregulated in astrocytes and microgliaJulia Tcw, Lu Qian, Nina H Pipalia, et al.
The Lancet. Neurology|June 20, 2025
Prediction of amyloid and tau brain deposition and cognitive decline in people with Down syndrome using plasma biomarkers: a longitudinal cohort studyShorena Janelidze, Lyduine E Collij, Niklas Mattsson-Carlgren, et al.
Pageof 37

Showing results (301-310 of 364) with videos related to

Sort By:
Pageof 37
Medrxiv : the Preprint Server for Health Sciences|December 16, 2024
The striatum is an early, accurate indicator of amyloid burden using [<sup>11</sup>C]PiB in Down syndrome: comparison of two radiotracersMax McLachlan, Brecca Bettcher, Andrew McVea, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 25, 2025
PET-measured amyloid beta accumulates at an accelerated rate in Down syndrome compared to neurotypical populationsAndrew McVea, Alexandra DiFilippo, Max McLachlan, et al.
Ebiomedicine|November 5, 2024
The effects of mosaicism on biological and clinical markers of Alzheimer's disease in adults with Down syndromeLaura Xicota, Lam-Ha T Dang, Alice Lee, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 21, 2026
The impact of congenital heart disease on the timing of Alzheimer's disease in Down syndromeJulianne G Clina, Brian C Helsel, Sigan L Hartley, et al.
Scientific Data|July 29, 2023
Multimodal neuroimaging data from a 5-week heart rate variability biofeedback randomized clinical trialHyun Joo Yoo, Kaoru Nashiro, Jungwon Min, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 7, 2020
Proteomic profiles for Alzheimer's disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimer's Biomarker Consortium-Down Syndrome (ABC-DS) studyMelissa E Petersen, Fan Zhang, Nicole Schupf, et al.
Medrxiv : the Preprint Server for Health Sciences|June 17, 2024
A Neuropathology Case Report of a Woman with Down Syndrome who Remained Cognitively StableJr-Jiun Liou, Jerry Lou, Jamie Nakagiri, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 16, 2025
Genome-wide association analyses identify candidate loci for amyloid imaging and plasma biomarkers in adults with Down syndromeM Muaaz Aslam, Lam-Ha T Dang, Ruyu Shi, et al.
Cell|June 24, 2022
Cholesterol and matrisome pathways dysregulated in astrocytes and microgliaJulia Tcw, Lu Qian, Nina H Pipalia, et al.
The Lancet. Neurology|June 20, 2025
Prediction of amyloid and tau brain deposition and cognitive decline in people with Down syndrome using plasma biomarkers: a longitudinal cohort studyShorena Janelidze, Lyduine E Collij, Niklas Mattsson-Carlgren, et al.
Pageof 37